Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral m…
Biotechnology
US, Menlo Park [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Corcept Therapeutics Incorporated can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCorcept Therapeutics Incorporated can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Corcept Therapeutics Incorporated.
If you want to see a demo, head over to the financial segments of AAPL